Certified by Founder Lodge
oncgnostics GmbH
Germany - Jena, Thüringen START UP
1 Disclosed Funding Rounds $0
0 Participating Investments
- Founded date
2012
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
oncgnostics develops – based on proprietary epigenetic biomarkers - highly reliable molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 11 ,2023 | Unknown | Undisclosed Amount |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Deacon Health Inc | $7,000,000 | (Apr 7, 2025)
Atsena Therapeutics | $150,000,000 | (Apr 7, 2025)
Vallor.ai (formerly Procuro) | $4,000,000 | (Apr 7, 2025)
TrialKit | $4,250,000 | (Apr 3, 2025)
TwinKnowledge | $3,700,000 | (Apr 3, 2025)
